Methylguanine DNA Methyl Transferase Activities, Glutathione S Transferase and Nitric Oxide in Bladder Cancer Patients

REFERENCES

• Dalbagni G., Presti J., Reuter V., Fair W. R., Cordon-Cardo C. Genetic alterations in bladder cancer. Lancet. 1993; 342(8869)469–471, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Karagas M. R., Park S., Warren A., Hamilton J., Nelson H. H., Mott L. A., Kelsey T. K. Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett. 2005; 219(1)63–69, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lafuente A., Pujol F., Carretero P., Villa J. P., Cuchi A. Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett. 1993; 68(1)49–54, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ames B. N., Shigenaga M. K., Hagen T. M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 1993; 90(17)7915–7922, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Srivenugopal K. S., Yuan X. H., Friedman H. S., Ali-Osman F. Ubiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea. Biochemistry 1996; 35(4)1328–1334, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Strauss B. S. The control of O6-methylguanine-DNA methyltransferase (MGMT) activity in mammalian cells: a pre-molecular view. Mutat. Res. 1990; 233(1–2)139–150, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Iwakuma T., Sakumi K., Nakatsuru Y., Kawate H., Igarashi H., Shiraishi A., Tsuzuki T., Ishikawa T., Sekiguchi M. High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase. Carcinogenesis 1997 18(8)1631–1635, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Pegg A. E., Wiest L., Mummert C., Stine L., Moschel R. C., Dolan M. E. Use of antibodies to human O6-alkylguanine-DNA alkyltransferase to study the content of this protein in cells treated with O6-benzylguanine or N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis 1991; 12(9)1679–1683, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Engel L. S., Taioli E., Pfeiffer R., Garcia-Closas M., Marcus P. M., Lan Q., Boffetta P., Vineis P., Autrup H., Bell D. A., Branch R. A., Brockmoller J., Daly A. K., Heckbert S. R., Kalina I., Kang D., Katoh T., Lafuente A., Lin H. J., Romkes M., Taylor J. A., Rothman N. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am. J. Epidemiol. 2002; 156(2)95–109, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Am. J. Epidemiol. 2002; 156(5)92, Review. Erratum in[CSA]
   Google Scholar
• Colvin O. M., Friedman H. S., Gamcsik M. P., Fenselau C., Hilton J. Role of glutathione in cellular resistance to alkylating agents. Adv. Enzyme Regul. 1993; 33: 19–26, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Dirven H. A., van Ommen B., van Bladeren P. J. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione. Cancer Res. 1994; 54(23)6215–6220, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hofseth L. J., Hussain S. P., Wogan G. N., Harris C. C. Nitric oxide in cancer and chemoprevention1. Free Radic. Biol. Med. 2003; 34(8)955–968, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Swana H. S., Smith S. D., Perrotta P. L., Saito N., Wheeler M. A., Weiss R. M. Inducible nitric oxide synthase with transitional cell carcinoma of the bladder. J. Urol. 1999; 161(2)630–634, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Vahakangas K., Trivers G. E., Plummer S., Hayes R. B., Krokan H., Rowe M., Swartz R. P., Yeager H., Jr., Harris C. C. O(6)-methylguanine-DNA methyltransferase and uracil DNA glycosylase in human broncho-alveolar lavage cells and peripheral blood mononuclear cells from tobacco smokers and non-smokers. Carcinogenesis 1991; 12(8)1389–1394, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bradford M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of proten-dye binding. Anal biochem. 1976; 72: 248–254, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Branch P., Hampson R., Karran P. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. Cancer Res. 1995; 55(11)2304–2309, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Karran P., Bignami M. Self-destruction and tolerance in resistance of mammalian cells to alkylation damage. Nucleic Acids Res. 1992; 20(12)2933–2940, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Habig W. H., Pabst M. J., Jakoby W. B. Glutathione S-transferases The first enzymatic step in mercapturic acid formation. J Biol. Chem. 1974; 249(22)130–139, [CSA]
   Google Scholar
• Badawi A. F., Mostafa M. H., O'Connor P. J. Involvement of alkylating agents in schistosome-associated bladder cancer: the possible basic mechanisms of induction. Cancer Lett. 1992; 63(3)171–188, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gutierrez M. I., Siraj A. K., Khaled H., Koon N., El-Rifai W., Bhatia K. CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer. Mod Pathol. 2004; 17(10)1268–1274, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Maruyama R., Toyooka S., Toyooka K. O., Harada K., Virmani A. K., Zochbauer-Muller S., Farinas A. J., Vakar-Lopez F., Minna J. D., Sagalowsky A., Czerniak B., Gazdar A. F. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res. 2001; 61(24)8659–8663, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kyrtopoulos S. A., Ampatzi P., Davaris, Haritopoulos N., Golematis B. Studies in gastric carcinogenesis. IV. O6-methlyguanine and its repair in normal and atrophic biopsy specimens of human gastric mucosa. Correlation of O6-alkylguanine-DNA alkyltransferase activities in gastic mucosa and circulating lymphocytes. Carcinogenesis 1990; 3: 431–436, [CSA]
   Google Scholar
• Musarrat J., Wilson J. A., Abou-Issa H., Wani A. A. O(6)-alkylguanine DNA alkyltransferase activity levels in normal, benign and malignant human female breast. Biochem. Biophys. Res. Commun. 1995; 208(2)688–696, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Huber W. W., Scharf G., Nagel G., Prustomersky S., Schulte-Hermann R., Kaina B. Coffee and its chemopreventive components Kahweol and Cafestol increase the activity of O6 methylguanine-DNA methyltransferase in rat liver–comparison with phase II xenobiotic metabolism. Mutat. Res. 2003; 522(1–2)57–68, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Souliotis V. L., Kyrtopoulos S. A. A novel, sensitive assay for O6-methyl- and O6-ethylguanine in DNA, based on repair by the enzyme O6-alkylguanine-DNA-alkyltransferase in competition with an oligonucleotide containing O6-methylguanine. Cancer Res. 1989; 49(24 Pt 1)6997–7001, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Dinçer Y., Akçay T., Celebi N., Uslu I., Ozmen O., Hatemi H., Glutathione S. Transferase and O6 methylguanine DNA methyltransferase activities in patients with thyroid papillary carcinoma. Cancer Invest. 2002; 20(7–8)965–971, [CSA]
   PubMed Web of Science ®Google Scholar
• Dinçer Y., Akçay T., Tortum O. B., Alademir Z., Onen S., Dogusoy G. Evaluation of O6-methlyguanine DNA methyltransferase activity in patients with gastrc cancer. Oncol. Res. 2003; 13(4)205–209, [CSA]
   PubMed Web of Science ®Google Scholar
• Lafuente A., Pujol F., Carretero P., Villa J. P., Cuchi A. Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett. 1993; 68(1)49–54, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lafuente A., Rodriguez A., Gibanel R., Lafuente M. J., Alonso M., Molina R., Ballesta A., Carretero P. Limitations in the use of glutathione S-transferase P1 in urine as a marker for bladder cancer. Anticancer Res. 1998; 18(5B)3771–3772, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Mirvish S. S. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett. 1995; 93(1)17–48, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Cancer Lett. 1995; 97(2)271, Review. Erratum in Nov 6[CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Mirvish S. S. Studies on experimental animals involving surgical procedures and/or nitrosamine treatment related to the etiology of esophageal adenocarcinoma. Cancer Lett. 1997; 117(2)161–174, Review[INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Klotz T., Bloch W., Volberg C., Engelmann U., Addicks K. Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 1998; 82(10)1897–1903, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Khalifa A., Eissa S., Aziz A. Determination of cytosolic citrulline and nitrate as indicators of nitric oxide in bladder cancer: possible assocation with basic fibroblast growth factor. Clin. Biochem. 1999; 32(8)635–638, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar